Semgo 14mg (Semaglutide) is an FDA approved oral medication used to manage Type 2 Diabetes Mellitus (T2DM) promote weight loss and reduce the risk of chronic kidney disease and major cardiovascular events. Available in 3mg 7mg and 14mg doses Semgo 14mg is effective in long term blood sugar control and overall health improvement.
Semgo 14mg (Semaglutide)
₨ 3,200
Description
Semgo 14mg (Semaglutide) – Powerful Oral Medication for Diabetes & Weight Management
Semgo 14mg (Semaglutide) is an advanced oral medication for Type 2 Diabetes Mellitus (T2DM) that was FDA-approved for use in September 2019. It is the first and only Semaglutide tablet formulation, providing an effective and convenient alternative to injectable diabetes medications.
Semgo 14mg is a GLP-1 receptor agonist that works by mimicking the effects of a natural hormone, improving insulin sensitivity, promoting insulin secretion, and suppressing appetite to help achieve weight loss. The oral tablets make it easier for patients to manage their blood sugar and reduce their risk of cardiovascular disease and chronic kidney problems.
The dosing schedule for Semgo 14mg is as follows:
-
Initiation Phase (Days 1–30): Start with 3mg orally once daily.
-
Days 31–60: Increase to 7mg once daily for better glycemic control.
-
Day 61 and onward: Increase to 14mg once daily if further glycemic control is needed.
-
Important: Do not take two 7mg tablets to achieve the 14mg dose.
Product Type & Quantity
-
Type: Oral tablet (Semaglutide)
-
Quantity: 10 tablets per pack
-
Strength/Dosage: 14mg
Composition
Each Semgo 14mg tablet contains:
-
Semaglutide (14mg) – The active ingredient that helps manage blood sugar and promote weight loss.
Indications
Semgo 14mg (Semaglutide) is indicated for:
-
Type 2 Diabetes Mellitus (T2DM): Improves blood sugar control and enhances insulin sensitivity.
-
Effective Weight Loss: Reduces appetite and supports fat burning.
-
Cardiovascular Risk Reduction: Reduces the risk of major cardiovascular events.
-
NASH Treatment: Helps manage non-alcoholic steatohepatitis (fatty liver disease).
How to Use/Dosage
-
Initiation Phase (Days 1–30): Take 3mg orally once daily.
-
Days 31–60: Increase to 7mg orally once daily for enhanced glycemic control.
-
Day 61 and onward: Increase to 14mg once daily if further glycemic control is needed.
-
Important: Do not take two 7mg tablets to achieve the 14mg dose.
